Parkinson’s gene therapy could improve motor symptoms

News

Author: Simge Eva DoganPublished: 14 November 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Young medical researcher

UK researchers are trialling an innovative gene therapy that could improve motor symptoms – such as tremors and rigidity – experienced by people with Parkinson’s.

The therapy, named AXO-Lenti-PD, has been developed by biopharmaceutical companies Oxford BioMedica and Axovant Sciences.

The trial will work with 30 participants living with Parkinson’s at hospitals in London and Cambridge, UK and Paris, France. The first stage will evaluate the safety and dosage of the therapy – and the second stage will assess the long-term effects of the therapy on motor function.

To read more on this topic click here.

For more information on Parkinson’s and gene therapy please visit the EPDA website.


Read more:

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

AI technology could diagnose Parkinson’s in less than three minutes

Go Back

Share this story

Comments


Related articles


Worried couple reading a letter

Special reports

£16,000 a year: the hidden price of Parkinson’s

Research reveals the monetary cost of Parkinson’s for UK families

READ MORE
Marijuana

Global update

The future of Parkinson’s and medicinal plants

The Parkinson’s Foundation hosts leading experts

READ MORE
Parkinson's

Interviews

“Since being diagnosed with Parkinson’s, my world has expanded”

The latest in our monthly series profiling WPC2019 bloggers

READ MORE